Terms: = Lymphoma AND CD52, CDW52, EDDM5 AND Prognosis
29 results:
1. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
Jakubikova J; Cholujova D; Beke G; Hideshima T; Klucar L; Leiba M; Jamroziak K; Richardson PG; Kastritis E; Dorfman DM; Anderson KC
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752202
[TBL] [Abstract] [Full Text] [Related]
2. [scRNA-sequencing uncovers metabolism and cd52 as new targets in ibrutinib-surviving mantle cell lymphoma cells].
Fuhr V; Vafadarnejad E; Dietrich O; Arampatzi P; Riedel A; Saliba AE; Rosenwald A; Rauert-Wunderlich H
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):31-35. PubMed ID: 36222922
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies.
Wada M; Zhang H; Fang L; Feng J; Tse CO; Zhang W; Chen Q; Sha S; Cao Y; Chen KH; Pinz KG; Chen X; Fan XX; Jiang X; Ma Y
Stem Cell Rev Rep; 2020 Apr; 16(2):369-384. PubMed ID: 32008159
[TBL] [Abstract] [Full Text] [Related]
4. Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis.
Lisenko K; Schönland SO; Jauch A; Andrulis M; Röcken C; Ho AD; Goldschmidt H; Hegenbart U; Hundemer M
Cancer Med; 2016 Jul; 5(7):1464-72. PubMed ID: 27109862
[TBL] [Abstract] [Full Text] [Related]
5. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
Sikaria S; Aldoss I; Akhtari M
Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
[TBL] [Abstract] [Full Text] [Related]
6. Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia.
Le Jeune C; Thomas X
Eur J Haematol; 2015 Feb; 94(2):99-108. PubMed ID: 24981395
[TBL] [Abstract] [Full Text] [Related]
7. The changing landscape of peripheral T-cell lymphoma in the era of novel therapies.
Karlin L; Coiffier B
Semin Hematol; 2014 Jan; 51(1):25-34. PubMed ID: 24468313
[TBL] [Abstract] [Full Text] [Related]
8. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
[TBL] [Abstract] [Full Text] [Related]
9. New drug therapies in peripheral T-cell lymphoma.
Howman RA; Prince HM
Expert Rev Anticancer Ther; 2011 Mar; 11(3):457-72. PubMed ID: 21417858
[TBL] [Abstract] [Full Text] [Related]
10. Ofatumumab: a new CD20 monoclonal antibody therapy for B-cell chronic lymphocytic leukemia.
O'Brien S; Osterborg A
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):361-8. PubMed ID: 21030349
[TBL] [Abstract] [Full Text] [Related]
11. A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report.
Angiolillo AL; Yu AL; Reaman G; Ingle AM; Secola R; Adamson PC
Pediatr Blood Cancer; 2009 Dec; 53(6):978-83. PubMed ID: 19637330
[TBL] [Abstract] [Full Text] [Related]
12. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.
Agostinelli C; Piccaluga PP; Went P; Rossi M; Gazzola A; Righi S; Sista T; Campidelli C; Zinzani PL; Falini B; Pileri SA
J Clin Pathol; 2008 Nov; 61(11):1160-7. PubMed ID: 18755717
[TBL] [Abstract] [Full Text] [Related]
13. Receptor-directed therapy of T-cell leukemias and lymphomas.
Morris JC; Waldmann TA; Janik JE
J Immunotoxicol; 2008 Apr; 5(2):235-48. PubMed ID: 18569395
[TBL] [Abstract] [Full Text] [Related]
14. Subcutaneous alemtuzumab for Sézary Syndrome in the very elderly.
Alinari L; Geskin L; Grady T; Baiocchi RA; Bechtel MA; Porcu P
Leuk Res; 2008 Aug; 32(8):1299-303. PubMed ID: 18096224
[TBL] [Abstract] [Full Text] [Related]
15. Management of advanced-stage peripheral T-cell lymphomas.
Kimby E
Curr Hematol Malig Rep; 2007 Oct; 2(4):242-8. PubMed ID: 20425376
[TBL] [Abstract] [Full Text] [Related]
16. Protein expression profile of celiac disease patient with aberrant T cell by two-dimensional difference gel electrophoresis.
De Re V; Simula MP; Caggiari L; Ortz N; Spina M; Da Ponte A; De Appolonia L; Dolcetti R; Canzonieri V; Cannizzaro R
Ann N Y Acad Sci; 2007 Aug; 1109():429-40. PubMed ID: 17785332
[TBL] [Abstract] [Full Text] [Related]
17. [Cutaneous lymphomas].
Bachelez H
Rev Prat; 2007 Mar; 57(5):469-75. PubMed ID: 17583131
[TBL] [Abstract] [Full Text] [Related]
18. Expression of cd52 in peripheral T-cell lymphoma.
Piccaluga PP; Agostinelli C; Righi S; Zinzani PL; Pileri SA
Haematologica; 2007 Apr; 92(4):566-7. PubMed ID: 17488672
[TBL] [Abstract] [Full Text] [Related]
19. The diagnosis, management, and role of hematopoietic stem cell transplantation in aggressive peripheral T-cell neoplasms.
Rezania D; Cualing HD; Ayala E
Cancer Control; 2007 Apr; 14(2):151-9. PubMed ID: 17387300
[TBL] [Abstract] [Full Text] [Related]
20. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
[TBL] [Abstract] [Full Text] [Related]
[Next]
